Interstitial pneumonia in EGFR-TKIs-treated non-small-cell lung cancer: report of 4 cases and review of the literature

杨庆羚; 刘翩; 王斌; 李运成; 范晔; 吴国明

您当前的位置：

首页 >

文章列表页 >

Interstitial pneumonia in EGFR-TKIs-treated non-small-cell lung cancer: report of 4 cases and review of the literature

更新时间：2026-01-09

- Interstitial pneumonia in EGFR-TKIs-treated non-small-cell lung cancer: report of 4 cases and review of the literature
- Journal of Army Medical University Vol. 34, Issue 20, Pages: 2060-2062(2012)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC： R563.13;R734.2;R979.1
- Published：2012
- 稿件说明：
移动端阅览
杨庆羚,刘翩,王斌,李运成,范晔,吴国明.EGFR-TKIs治疗晚期非小细胞肺癌并发间质性肺炎4例报告并文献复习[J].陆军军医大学学报(原第三军医大学学报),2012,34(20):2060-2062.

　Yang Qingling,Liu Pian,Wang Bin,Li Yuncheng,Fan Ye,Wu Guoming.Interstitial pneumonia in EGFR-TKIs-treated non-small-cell lung cancer: report of 4 cases and review of the literature[J].J Amry Med Univ (J Third Mil Med Univ),2012,34(20):2060-2062.
杨庆羚,刘翩,王斌,李运成,范晔,吴国明.EGFR-TKIs治疗晚期非小细胞肺癌并发间质性肺炎4例报告并文献复习[J].陆军军医大学学报(原第三军医大学学报),2012,34(20):2060-2062. DOI：

　Yang Qingling,Liu Pian,Wang Bin,Li Yuncheng,Fan Ye,Wu Guoming.Interstitial pneumonia in EGFR-TKIs-treated non-small-cell lung cancer: report of 4 cases and review of the literature[J].J Amry Med Univ (J Third Mil Med Univ),2012,34(20):2060-2062. DOI：

摘要

目的总结表皮生长因子受体酪氨酸激酶抑制剂（epidermal growth factor receptor tyrosine kinase inhibitors，EGFR-TKIs）在治疗晚期非小细胞肺癌（non-small cell lung cancer，NSCLC）中所致间质性肺炎的临床表现、诊断和治疗。方法回顾性分析我科4例晚期NSCLC患者靶向治疗药物致间质性肺炎的临床表现、诊断、治疗经过及转归。结果 4例晚期NSCLC患者均接受了化疗，并分别因化疗后病情进展或不能耐受进一步化疗而口服吉非替尼或厄洛替尼，在EGFR-TKIs治疗后30 d内出现呼吸困难、咳嗽和低氧血症，并发间质性肺炎，其中3例病情进展迅速，因呼吸衰竭死亡，提示其预后凶险。结论对接受EGFR-TKIs治疗的患者，一旦出现呼吸困难和咳嗽，应及时进行胸部CT、肺功能、血气分析等相关检查。该类间质性肺炎预后凶险，病死率很高，一旦确诊间质性肺炎，应立即停用EGFR-TKIs，并及时予以足量激素及氧疗等对症治疗，必要时进行呼吸支持，才有可能改善其预后。

Abstract

Objective To identify the clinical features

diagnosis and treatment of interstitial pneumonia related to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) which were used in advanced non-small cell lung cancer(NSCLC). Methods Retrospective analysis was carried out in 4 cases with NSCLC who developed interstitial pneumonia after EGFR-TKIs therapy in our department from March 2007 to September 2011. Their clinical features

diagnosis

treatment and outcome were analyzed. Results The 4 patients had previously received chemotherapy until disease progression or unacceptable toxicity and then turned to receive gefitinib or erlotinib orally. However

within 30 d after the treatment

the patients suffered from dyspnea

cough and hypoxemia and developed interstitial pneumonia. Three patients died of respiratory failure due to rapid disease progression

which reflected the poor prognosis of the interstitial pneumonia. Conclusion EGFR-TKIs-related interstitial pneumonia is with poor prognosis and high mortality. Timely chest CT scanning

pulmonary function testing

blood gas analysis and other tests should be performed as soon as dyspnea

cough and hypoxemia are seen. Relevant treatment such as discontinuation of EGFR-TKIs immediately

use of corticosteroids

oxygen therapy and respiration supporting when necessary

can probably improve the prognosis and survival of patients.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Efficacy and resistance of EGFR-TKIs for first-line treatment for compound EGFR mutations positive non-small cell lung cancer

Survival benefit and failure patterns of EGFR-TKIs in elderly patients with advanced non-small cell lung cancer

Integrative model combining deep learning, clinical and radiomic features enhances EGFR mutation prediction in non-small cell lung cancer

Preparation of doxorubicin-loaded polyphyllin H liposomes and synergistic anti-tumor activity against non-small cell lung cancer in vitro

Development of a postoperative recurrence prediction model for stage Ⅰ non-small cell lung cancer patients using multimodal data based on machine learning

Related Author

管旭辉

林晓程

杨衿记

陈华军

杨衿记

严红虹

王震

汪斌超

Related Institution

Department of Diagnostic Radiology， Eastern Theatre General Hospital

Department of Radiology， Daping Hospital， Army Medical University

Infervision Medical Technology Co.， Ltd

Department of Radiology，First Affiliated Hospital， Army Medical University （Third Military Medical University）

Department of Medical Service,No. Hospital of Joint Logistics Support Force

⁰